Cover Image
市場調查報告書

CytoTools AG : 產品平台分析

CytoTools AG - Product Pipeline Review - 2015

出版商 Global Markets Direct 商品編碼 256098
出版日期 內容資訊 英文 29 Pages
訂單完成後即時交付
價格
Back to Top
CytoTools AG : 產品平台分析 CytoTools AG - Product Pipeline Review - 2015
出版日期: 2015年08月26日 內容資訊: 英文 29 Pages
簡介

CytoTools AG(原CytoTools GmbH)是提供調查服務的生物科技企業,正在開發創傷治療,泌尿道感染,心血管疾病用的新治療方法和醫藥品。

本報告提供USV Limited的治療藥開發平台現狀及各開發階段比較分析,提供您藥物標的,作用機制,給藥途徑,各分子類型的治療藥評估,最新的企業新聞和發表,後期階段及中止的計劃等相關資訊。

CytoTools AG的基本資料

  • CytoTools AG概要
  • 主要資訊
  • 企業資料

CytoTools AG :R&D概要

  • 主要的治療範圍

CytoTools AG :開發平台評估

  • 各開發階段的開發中產品
  • 單劑產品

CytoTools AG :開發中產品概況

  • 後期階段產品開發中產品
    • 登記前的產品/聯合治療模式
    • 第三階段的產品/聯合治療模式
  • 臨床階段的開發中產品
    • 第二階段的產品/聯合治療模式
    • 第一階段的產品/聯合治療模式
  • 初期階段的開發中產品
    • 前臨床階段的產品/聯合治療模式
    • 藥物研發階段的產品/聯合治療模式

CytoTools AG :藥物簡介

  • CL-05
  • PEP-04
  • HMW-02Ak
  • HMW-02Ap
  • LMW-0X

CytoTools AG :開發平台分析

  • 各給藥途徑
  • 各分子類型

CytoTools AG :最近的開發平台趨勢

CytoTools AG :暫停中的計劃

CytoTools AG :總公司和子公司的所在地

附錄

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GMDHC07465CDB

Summary

Global Markets Direct's, 'CytoTools AG - Product Pipeline Review - 2015', provides an overview of the CytoTools AG's pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of CytoTools AG's, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of CytoTools AG including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of CytoTools AG's human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the CytoTools AG's pipeline products

Reasons to buy

  • Evaluate CytoTools AG's strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of CytoTools AG in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the CytoTools AG's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of CytoTools AG and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of CytoTools AG
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of CytoTools AG and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • CytoTools AG Snapshot
    • CytoTools AG Overview
    • Key Information
    • Key Facts
  • CytoTools AG - Research and Development Overview
    • Key Therapeutic Areas
  • CytoTools AG - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
  • CytoTools AG - Pipeline Products Glance
    • CytoTools AG - Late Stage Pipeline Products
      • Pre-Registration Products/Combination Treatment Modalities
      • Phase III Products/Combination Treatment Modalities
    • CytoTools AG - Clinical Stage Pipeline Products
      • Phase II Products/Combination Treatment Modalities
      • Phase I Products/Combination Treatment Modalities
    • CytoTools AG - Early Stage Pipeline Products
      • Preclinical Products/Combination Treatment Modalities
      • Discovery Products/Combination Treatment Modalities
  • CytoTools AG - Drug Profiles
    • CL-05
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • PEP-04
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • HMW-02Ak
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • HMW-02Ap
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • LMW-0X
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • CytoTools AG - Pipeline Analysis
    • CytoTools AG - Pipeline Products by Route of Administration
    • CytoTools AG - Pipeline Products by Molecule Type
  • CytoTools AG - Recent Pipeline Updates
  • CytoTools AG - Dormant Projects
  • CytoTools AG - Locations And Subsidiaries
    • Head Office
    • Other Locations & Subsidiaries
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • CytoTools AG, Key Information
  • CytoTools AG, Key Facts
  • CytoTools AG - Pipeline by Indication, 2015
  • CytoTools AG - Pipeline by Stage of Development, 2015
  • CytoTools AG - Monotherapy Products in Pipeline, 2015
  • CytoTools AG - Pre-Registration, 2015
  • CytoTools AG - Phase III, 2015
  • CytoTools AG - Phase II, 2015
  • CytoTools AG - Phase I, 2015
  • CytoTools AG - Preclinical, 2015
  • CytoTools AG - Discovery, 2015
  • CytoTools AG - Pipeline by Route of Administration, 2015
  • CytoTools AG - Pipeline by Molecule Type, 2015
  • CytoTools AG - Recent Pipeline Updates, 2015
  • CytoTools AG - Dormant Developmental Projects,2015
  • CytoTools AG, Subsidiaries

List of Figures

  • CytoTools AG - Pipeline by Top 10 Indication, 2015
  • CytoTools AG - Pipeline by Stage of Development, 2015
  • CytoTools AG - Monotherapy Products in Pipeline, 2015
  • CytoTools AG - Pipeline by Top 10 Route of Administration, 2015
  • CytoTools AG - Pipeline by Top 10 Molecule Type, 2015
Back to Top